ineo ag
Company Overview
Previous Company Names
- GfB Terges
- ICB Innovation Capital AG
- (ICB Innovation Capital Ltd) (ICB Innovation Capital SA)
- ineo
Management
Werner René Rein
Zug
Chairperson of the board
Joint signing authority (any two to sign)
Cyrille du Pasquier
Signy
Member of the board
Joint signing authority (any two to sign)
Patrik Frei
Zürich
Member of the board
Joint signing authority (any two to sign)
Werner Rein
Ascona
Chairperson of the board
Joint signing authority (any two to sign)
Markus Frei
Oberwil bei Zug
Member of the board
Joint signing authority (any two to sign)
Rudolf Heer
Zürich
Chairperson of the board
Joint signing authority (any two to sign)
René Kästli
Jona
Member of the board
Individual signing authority
Reto Casserini
Zürich
Having right to sign
Joint signing authority (any two to sign)
Kristijan Goricanec
Zürich
Having right to sign
Joint signing authority (any two to sign)
Markus Bigler
Biel BE
Member of the board
Joint signing authority (any two to sign)
Derek Bing Han
Zürich
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 6796 | 20.05.2011 | 101 | 25.05.2011 | 6178142 |
| 2 | 6857 | 30.04.2009 | 86 | 06.05.2009 | 25/5005948 |
| 3 | 645 | 14.01.2009 | 12 | 20.01.2009 | 26/4833826 |
| 4 | 11068 | 14.08.2008 | 160 | 20.08.2008 | 20/4618706 |
| 5 | 3890 | 22.03.2007 | 61 | 28.03.2007 | 21/3859658 |
| 6 | 1839 | 13.02.2007 | 34 | 19.02.2007 | 25/3784982 |
| 7 | 12394 | 13.10.2006 | 203 | 19.10.2006 | 15/3598814 |
| 8 | 8964 | 25.07.2006 | 146 | 31.07.2006 | 15/3489932 |
| 9 | 10040 | 13.09.2005 | 181 | 19.09.2005 | 17/3022880 |
| 10 | 8529 | 04.08.2005 | 153 | 10.08.2005 | 15/2967940 |
Company Purpose
Halten und Verwalten von direkten und indirekten Kapitalanlagen an Unternehmen; kann Beteiligungen erwerben, verwalten und veräussern sowie Tochtergesellschaften gründen; wird Investitionen in ein Risikokapital-Portfolio mit Investitionsschwerpunkt Europa tätigen, hauptsächlich in den Bereichen Medizinal-, Bio- und Nanotechnologie sowie in der Informations- und Kommunikationstechnologie